
NASDAQ:RXDX • US74349U1088
Past quarterly earnings results for PROMETHEUS BIOSCIENCES INC (RXDX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2023 | -0.86 | -0.93 | 7.45% | -4.88% | 1.105M | 517.65K | 113.46% | -71.80% |
| Q4 2022 | -0.90 | -0.94 | 4.21% | -16.88% | 653K | 590.692K | 10.55% | -37.03% |
| Q3 2022 | -0.90 | -0.92 | 2.44% | -28.57% | 968K | 654.503K | 47.90% | -3.78% |
| Q2 2022 | -0.86 | -0.93 | 7.69% | -75.51% | 1.269M | 520.649K | 143.73% | 289.26% |
| Q1 2022 | -0.82 | -0.81 | -1.40% | 50.90% | 3.919M | 669.293K | 485.54% | 415.66% |
| Q4 2021 | -0.77 | -0.69 | -11.30% | - | 1.037M | 554.584K | 86.99% | - |
| Q3 2021 | -0.70 | -0.60 | -17.11% | - | 1.006M | 357K | 181.79% | - |
| Q2 2021 | -0.49 | -0.40 | -23.60% | - | 326K | 153K | 113.07% | 82.12% |
| Q1 2021 | -1.67 | -0.38 | -341.31% | - | 760K | 204K | 272.55% | 233.33% |
| Q2 2020 | - | - | 179K | - | - | |||
| Q1 2020 | - | - | 228K | - | - |
Notes
PROMETHEUS BIOSCIENCES INC (RXDX) last reported earnings on 5/9/2023.
PROMETHEUS BIOSCIENCES INC (RXDX) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, PROMETHEUS BIOSCIENCES INC (RXDX) has beaten EPS estimates in 4 out of 4 releases.